Name
Title
Email
Robert Goldsmith
Senior Vice President, Corporate Development, MJH Life Sciences & OncLive®
rgoldsmith@mjhassoc.com
Lisa Greene
Vice President, Sales, OncLive® Medical
lgreene@onclive.com
Morgan Michon
Director of Sales, OncLive®
mmichon@onclive.com
Elisha Ball
Associate Director, Sales, OncLive® Events
egarcia@onclive.com
Alyssa Tomaseck
Business Development Manager, OncLive® Medical
atomaseck@onclive.com
Mike DiGrazia
National Account Associate, OncLive®
mdigrazia@onclive.com
John Marshall
jmarshall@onclive.com
Jack Nirenberg
jnirenberg@onclive.com
Marco Gaita
mgaita@onclive.com
Bryn Fitchett
bfitchett@onclive.com
Maddison Martini
mmartini@mjhlifesciences.com
Luveltamab Tazevibulin Produces Responses in Platinum-Resistant Ovarian Cancer With Low/Medium FRα Expression
BVAC-C Vaccine Therapy Plus Durvalumab Elicits Responses in Recurrent HPV+ Cervical Cancer
Updated MIRASOL Data Support Mirvetuximab Soravtansine as SOC for FRα+ Platinum-Resistant Ovarian Cancer
Cyclin E1 Positivity Predicts Response to Azenosertib in Platinum-Resistant Ovarian Cancer
